Sequence information
Variant position: 85 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 424 The length of the canonical sequence.
Location on the sequence:
PPRKRLKSKGSDKDFVIVRR
P KLNRENFPGVSWDSLPDELL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PPRKRLKSKGSDKDFVIVRRP KLNRENFPGVSWD--SLPDELL
Mouse PPRKRVKGKGSDKDFVIIRRP KLSRENFPGVSWD--SLPDE
Baker's yeast IIAGSYKLDSYDKDVKKLNNI RLNDET-PIITSERIKLLDK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 424
S-phase kinase-associated protein 2
Region
1 – 220
Mediates interaction with hepatitis C virus non-structural protein NS5A
Modified residue
68 – 68
N6-acetyllysine; by p300/EP300
Modified residue
71 – 71
N6-acetyllysine; by p300/EP300
Modified residue
72 – 72
Phosphoserine
Modified residue
75 – 75
Phosphoserine
Alternative sequence
1 – 169
Missing. In isoform 3.
Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.